Teva Pharmaceutical Industries Limited (TLV:TEVA)
6,442.00
+78.00 (1.23%)
Oct 28, 2025, 2:44 PM IDT
TLV:TEVA Market Cap
TLV:TEVA has a market cap or net worth of 73.29 billion as of October 28, 2025. Its market cap has decreased by -1.22% in one year.
Market Cap
73.29B
Enterprise Value
123.42B
Revenue
56.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,442.00
Market Cap Chart
Since June 26, 1992, TLV:TEVA's market cap has increased from 1.72B to 73.29B, an increase of 4,161.65%. That is a compound annual growth rate of 11.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 73.29B | -19.53% |
| Dec 31, 2024 | 91.08B | 116.11% |
| Dec 29, 2023 | 42.15B | 18.33% |
| Dec 30, 2022 | 35.62B | 29.61% |
| Dec 31, 2021 | 27.48B | -19.18% |
| Dec 31, 2020 | 34.00B | -8.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 3.02B |
| Kamada | 1.30B |
| SofWave Medical | 1.09B |
| BrainsWay | 1.05B |
| Bait Bakfar | 1.04B |
| Ilex Medical | 726.67M |
| Novolog (Pharm-Up 1966) | 662.09M |
| Bonus BioGroup | 269.79M |